|
CA3109430A1
|
|
Neoantigen targeting dna vaccine for combination therapy
|
|
KR20190125481A
|
|
New PD-L1 Targeting DNA Vaccine for Immunotherapeutic in Cancer
|
|
EP3583200A1
|
|
Novel vegfr-2 targeting immunotherapy approach
|
|
BR112019009003A2
|
|
attenuated salmonella strain and pharmaceutical composition
|
|
AU2017295004A1
|
|
Process for the production of a DNA vaccine for cancer immunotherapy
|
|
US2018250345A1
|
|
VEGFR-2 targeting DNA vaccine for combination therapy
|
|
US2018153976A1
|
|
Novel cmv pp65 targeting dna vaccine for cancer immunotherapy
|
|
WO2014173542A1
|
|
Salmonella-based vectors for cancer immunotherapy targeting wilms' tumor gene wt1
|
|
AU2013286335A1
|
|
DNA vaccine for use in pancreatic cancer patients
|
|
MX2014007575A
|
|
Method for producing high yield attenuated salmonella strains.
|
